AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) in combination with pertuzumab has been approved in the USA ...
The US Food and Drug Administration (FDA) yesterday removed a key limitation on the use of real-world evidence (RWE) used in ...
UK-based Bicycle Therapeutics, a pharma company developing a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, has entered into a 15-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback